BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 34167558)

  • 41. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
    Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
    Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia.
    Cheng F; Li Q; Wang J; Wang L; Li W; Zeng F
    Dis Markers; 2022; 2022():3199589. PubMed ID: 35280440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells.
    Domingues AF; Kulkarni R; Giotopoulos G; Gupta S; Vinnenberg L; Arede L; Foerner E; Khalili M; Adao RR; Johns A; Tan S; Zeka K; Huntly BJ; Prabakaran S; Pina C
    Elife; 2020 Jan; 9():. PubMed ID: 31985402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of Slug effectively targets leukemia stem cells via the Slc13a3/ROS signaling pathway.
    Zhang Z; Li L; Wu C; Yin G; Zhu P; Zhou Y; Hong Y; Ni H; Qian Z; Wu WS
    Leukemia; 2020 Feb; 34(2):380-390. PubMed ID: 31492896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML.
    Sheng Y; Yu C; Liu Y; Hu C; Ma R; Lu X; Ji P; Chen J; Mizukawa B; Huang Y; Licht JD; Qian Z
    Nat Commun; 2020 Feb; 11(1):928. PubMed ID: 32066721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia.
    Zhou F; Liu Y; Rohde C; Pauli C; Gerloff D; Köhn M; Misiak D; Bäumer N; Cui C; Göllner S; Oellerich T; Serve H; Garcia-Cuellar MP; Slany R; Maciejewski JP; Przychodzen B; Seliger B; Klein HU; Bartenhagen C; Berdel WE; Dugas M; Taketo MM; Farouq D; Schwartz S; Regev A; Hébert J; Sauvageau G; Pabst C; Hüttelmaier S; Müller-Tidow C
    Nat Cell Biol; 2017 Jul; 19(7):844-855. PubMed ID: 28650479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells.
    Bill M; Papaioannou D; Karunasiri M; Kohlschmidt J; Pepe F; Walker CJ; Walker AE; Brannan Z; Pathmanathan A; Zhang X; Mrózek K; LaRocco A; Volinia S; Bloomfield CD; Garzon R; Dorrance AM
    Leukemia; 2019 Sep; 33(9):2169-2182. PubMed ID: 30858548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nucleotide binding domain and leucine-rich repeat pyrin domain-containing protein 12: characterization of its binding to hematopoietic cell kinase.
    Zhang Y; Okamoto CT
    Int J Biol Sci; 2020; 16(9):1507-1525. PubMed ID: 32226298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.
    Wong P; Iwasaki M; Somervaille TC; So CW; Cleary ML
    Genes Dev; 2007 Nov; 21(21):2762-74. PubMed ID: 17942707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
    Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-148a-3p suppresses the progression of acute myeloid leukemia via targeting cyclin-dependent kinase 6 (CDK6).
    Zhou H; Jia X; Yang F; Shi P
    Bioengineered; 2021 Dec; 12(1):4508-4519. PubMed ID: 34308752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quiescence regulation by normal haematopoietic stem cells and leukaemia stem cells.
    Gudmundsson KO; Du Y
    FEBS J; 2023 Aug; 290(15):3708-3722. PubMed ID: 35514133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SOX12: a novel potential target for acute myeloid leukaemia.
    Wan H; Cai J; Chen F; Zhu J; Zhong J; Zhong H
    Br J Haematol; 2017 Feb; 176(3):421-430. PubMed ID: 27858992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of TG-Interacting Factor 1 decreases survival in mouse models of myeloid leukaemia.
    Yan L; Davé UP; Engel M; Brandt SJ; Hamid R
    J Cell Mol Med; 2020 Nov; 24(22):13472-13480. PubMed ID: 33058427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia.
    Grenier JMP; Testut C; Fauriat C; Mancini SJC; Aurrand-Lions M
    Front Immunol; 2021; 12():756231. PubMed ID: 34867994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.
    Nguyen CH; Bauer K; Hackl H; Schlerka A; Koller E; Hladik A; Stoiber D; Zuber J; Staber PB; Hoelbl-Kovacic A; Purton LE; Grebien F; Wieser R
    Cell Death Dis; 2019 Dec; 10(12):944. PubMed ID: 31822659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting leukemic stem cell subpopulation in AML using phytochemicals: An in-silico and in-vitro approach.
    Brahmbhatt J; Kumar SP; Bhadresha K; Patel M; Rawal R
    Comput Biol Med; 2023 Mar; 155():106644. PubMed ID: 36774886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling.
    Zhang Y; Xia F; Liu X; Yu Z; Xie L; Liu L; Chen C; Jiang H; Hao X; He X; Zhang F; Gu H; Zhu J; Bai H; Zhang CC; Chen GQ; Zheng J
    J Clin Invest; 2018 May; 128(5):1737-1751. PubMed ID: 29584620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
    Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
    Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells.
    Zhang H; Li H; Xi HS; Li S
    Blood; 2012 Mar; 119(11):2595-607. PubMed ID: 22275380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.